BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16818772)

  • 1. Roles of the Ig kappa light chain intronic and 3' enhancers in Igk somatic hypermutation.
    Inlay MA; Gao HH; Odegard VH; Lin T; Schatz DG; Xu Y
    J Immunol; 2006 Jul; 177(2):1146-51. PubMed ID: 16818772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ig(kappa) enhancer influences the ratio of Ig(kappa) versus Ig(lambda) B lymphocytes.
    Gorman JR; van der Stoep N; Monroe R; Cogne M; Davidson L; Alt FW
    Immunity; 1996 Sep; 5(3):241-52. PubMed ID: 8808679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The IgH 3' regulatory region controls somatic hypermutation in germinal center B cells.
    Rouaud P; Vincent-Fabert C; Saintamand A; Fiancette R; Marquet M; Robert I; Reina-San-Martin B; Pinaud E; Cogné M; Denizot Y
    J Exp Med; 2013 Jul; 210(8):1501-7. PubMed ID: 23825188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
    Komori A; Xu Z; Wu X; Zan H; Casali P
    Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci.
    Inlay MA; Lin T; Gao HH; Xu Y
    J Exp Med; 2006 Jul; 203(7):1721-32. PubMed ID: 16785310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential roles of the kappa light chain intronic enhancer and 3' enhancer in kappa rearrangement and demethylation.
    Inlay M; Alt FW; Baltimore D; Xu Y
    Nat Immunol; 2002 May; 3(5):463-8. PubMed ID: 11967540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoglobulin kappa enhancers are differentially regulated at the level of chromatin structure.
    Nikolajczyk BS; Sardi SH; Tumang JR; Ganley-Leal LM
    Mol Immunol; 2007 Jul; 44(13):3407-15. PubMed ID: 17382392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Switch recombination and somatic hypermutation are controlled by the heavy chain 3' enhancer region.
    Dunnick WA; Collins JT; Shi J; Westfield G; Fontaine C; Hakimpour P; Papavasiliou FN
    J Exp Med; 2009 Nov; 206(12):2613-23. PubMed ID: 19887393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classical Mus musculus Igκ enhancers support transcription but not high level somatic hypermutation from a V-lambda promoter in chicken DT40 cells.
    Kothapalli NR; Norton DD; Fugmann SD
    PLoS One; 2011 Apr; 6(4):e18955. PubMed ID: 21533098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Downstream Transcriptional Enhancer, Ed, positively regulates mouse Ig kappa gene expression and somatic hypermutation.
    Xiang Y; Garrard WT
    J Immunol; 2008 May; 180(10):6725-32. PubMed ID: 18453592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-step generation of monoclonal B cell receptor mice capable of isotype switching and somatic hypermutation.
    Jacobsen JT; Mesin L; Markoulaki S; Schiepers A; Cavazzoni CB; Bousbaine D; Jaenisch R; Victora GD
    J Exp Med; 2018 Oct; 215(10):2686-2695. PubMed ID: 30181412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Model of Somatic Hypermutation Targeting in Mice Based on High-Throughput Ig Sequencing Data.
    Cui A; Di Niro R; Vander Heiden JA; Briggs AW; Adams K; Gilbert T; O'Connor KC; Vigneault F; Shlomchik MJ; Kleinstein SH
    J Immunol; 2016 Nov; 197(9):3566-3574. PubMed ID: 27707999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of E mu, 3'alpha (hs 1,2) and 3'kappa enhancers on mutation of an Ig-VDJ-Cgamma2a Ig heavy gene in cultured B cells.
    Lin MM; Green NS; Zhang W; Scharff MD
    Int Immunol; 1998 Aug; 10(8):1121-9. PubMed ID: 9723698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic 'choice' governs somatic hypermutation in vivo at the immunoglobulin kappa-chain locus.
    Fraenkel S; Mostoslavsky R; Novobrantseva TI; Pelanda R; Chaudhuri J; Esposito G; Jung S; Alt FW; Rajewsky K; Cedar H; Bergman Y
    Nat Immunol; 2007 Jul; 8(7):715-22. PubMed ID: 17546032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.
    Buerstedde JM; Alinikula J; Arakawa H; McDonald JJ; Schatz DG
    PLoS Biol; 2014 Apr; 12(4):e1001831. PubMed ID: 24691034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
    Yang SY; Fugmann SD; Schatz DG
    J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.
    Klotz EL; Storb U
    J Immunol; 1996 Nov; 157(10):4458-63. PubMed ID: 8906822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Igκ gene enhancers, E3' and Ed, are essential for triggering transcription.
    Zhou X; Xiang Y; Garrard WT
    J Immunol; 2010 Dec; 185(12):7544-52. PubMed ID: 21076060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunoglobulin heavy chain gene 3' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells.
    Xiang H; Noonan EJ; Wang J; Duan H; Ma L; Michie S; Boxer LM
    Leukemia; 2011 Sep; 25(9):1484-93. PubMed ID: 21606958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lambda 3' enhancer drives active and untemplated somatic hypermutation of a lambda 1 transgene.
    Kong Q; Zhao L; Subbaiah S; Maizels N
    J Immunol; 1998 Jul; 161(1):294-301. PubMed ID: 9647236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.